Acceptability of Depo-subQ Provera 104 in Uniject vs. Intramuscular Depo-Provera Among HIV+ Women & Providers, Uganda

This study has been completed.
Sponsor:
Collaborators:
Society of Family Planning
Bill and Melinda Gates Foundation
Rakai Health Sciences Program
Information provided by (Responsible Party):
Ronald Gray, Johns Hopkins Bloomberg School of Public Health
ClinicalTrials.gov Identifier:
NCT01578447
First received: April 4, 2012
Last updated: September 16, 2014
Last verified: September 2014